News Eli Lilly says new Alzheimer’s drug donanemab slows early stages of disease by 35% May 3, 2023Ken Alltucker, USA TODAYComments Off on Eli Lilly says new Alzheimer’s drug donanemab slows early stages of disease by 35% Lilly said people on the drug donanemab slowed decline by 35% based on a measure of daily activities such as driving and talking about current events.